Cómo pagar por la prueba Oncotype DX

En los Estados Unidos

Todas las principales compañías de seguros cubren la prueba Oncotype DX para pacientes elegibles con cáncer de mama invasivo en etapa temprana. Medicare ha establecido una cobertura para la prueba Oncotype DX para pacientes con cáncer de mama DCIS (no invasivo), aunque la cobertura fuera de Medicare variará según la póliza de seguro.

En Canadá

En todas las provincias canadienses (Columbia Británica, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, Nueva Escocia, Isla del Príncipe Eduardo, Nuevo Brunswick y Terranova), la prueba cuenta con financiación pública para pacientes con cáncer de mama invasor en etapa inicial con con ganglios negativos. La prueba también cuenta con financiación pública para pacientes con cáncer de mama con ganglios positivos (1-3 ganglios) en Saskatchewan, Manitoba y Terranova. Pacientes particulares también tienen la opción de pagar independientemente por la prueba si no hay cobertura en su provincia o si no reúnen los criterios de elegibilidad provinciales preestablecidos.

Si tiene alguna pregunta sobre seguros y ayuda financiera, comuníquese con el Servicio de Atención al Cliente de Exact Sciences:

Llame a los siguientes teléfonos:

Norteamérica (inglés) - 855-5000-ASK (855-500-0275)
Norteamérica (español) - 844-4-MI-ONCO (844-464-6626)
Internacional - 001-650-569-2080

Correo electrónico

EE.UU.: oncotype@exactsciences.com
Canadá/Internacional: International@exactsciences.com

Genomic Health maintains the MyBreastCancerTreatment.org Web site as a service to the Internet community. The site has been designed to provide general information about breast cancer treatment decisions and about Genomic Health's laboratory test, Oncotype DX. The information on this Web site is provided solely on an "AS IS" and "AS AVAILABLE" basis. Genomic Health is not engaged in rendering investment or medical advice via this Web site, nor does it provide instruction on the appropriate use of laboratory tests offered, furnished or under development by Genomic Health, its affiliates, related companies, or its licensors or joint venture partners. Access and use of this site is subject to the terms and conditions set forth herein and all applicable laws, statutes, and/or regulations. Genomic Health does not, by or through this Web site, offer for sale any products or services. Oncotype DX is a diagnostic test that can only be ordered by an authorized healthcare professional.

Genomic Health may revise or modify these terms and conditions from time to time. Such changes, revisions, or modifications shall be effective immediately upon notice to you, which may be given by any means, including, without limitation, posting on the MyBreastCancerTreatment.org Web site. Any use of this Web site by you after such notice shall be deemed to constitute acceptance of the changes.

Genomic Health will use reasonable efforts to include accurate and up-to-date information on the MyBreastCancerTreatment.org site. However, any information presented on the Web site as of a particular date may only be accurate as of such date and Genomic Health disclaims any responsibility to update such information. Information about companies other than Genomic Health contained in news, press releases or otherwise that are posted on the Web site should not be relied upon as being provided or endorsed by Genomic Health.

ALL CONTENT ON THIS WEB SITE IS PROVIDED TO YOU ON AN "AS IS" AND "AS AVAILABLE" BASIS WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT. Genomic Health makes no warranty as to the accuracy, completeness, currency, or reliability of any content available through this Web site. You are responsible for verifying any information before relying on it. Use of the Web site and the content available on the Web site is at your sole risk. Genomic Health makes no representations or warranties that use of the Web site will be uninterrupted or error-free. You are responsible for taking all necessary precautions to ensure that any content you obtain from the Web site is free of viruses.

GENOMIC HEALTH SHALL NOT BE HELD RESPONSIBLE FOR ANY ACTION TAKEN THAT IS BASED ON THE INFORMATION PRESENTED ON THE MYBREASTCANCERTREATMENT.ORG WEB SITE. GENOMIC HEALTH EXPRESSLY DISCLAIMS ANY LIABILITY, WHETHER BASED IN CONTRACT, TORT, STRICT LIABILITY OR OTHERWISE, FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR SPECIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH ACCESS TO OR USE OF THE WEB SITE, EVEN IF GENOMIC HEALTH HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, INCLUDING BUT NOT LIMITED TO RELIANCE BY ANY PARTY ON ANY CONTENT OBTAINED THROUGH THE USE OF THE WEB SITE, THE INABILITY TO USE THE WEB SITE, OR ANY ERRORS OR OMISSIONS IN THE CONTENT OF THE WEB SITE.

By submitting any communication or material to Genomic Health, you agree that: (1) if you are a healthcare professional you will not submit any information that would identify a patient or any information for which you do not have all necessary consents or authorizations to disclose; (2) you will only submit content that complies with applicable law, and will not submit content that is abusive, defamatory, obscene, infringing, threatening, repetitive, or otherwise inappropriate, or that contains any viruses or other software that may adversely affect the operation of another's computer; (3) such content will be deemed non-confidential; and (4) you grant to Genomic Health the irrevocable right to use, copy, modify, publish, perform, transmit and display such content via any media in accordance with Genomic Health's Privacy Policy, and waive any moral rights you may have in such content. Subject to Genomic Health's Privacy Policy, Genomic Health shall be free to use such content, including any ideas, concepts, know-how, or techniques contained in such content, for any reason.

It is the policy of Genomic Health to enforce its intellectual property rights to the fullest extent permitted by law. All product names, regardless of whether or not they appear in large print or with a trademark symbol, are the trademarks and service marks of Genomic Health, its affiliates, related companies, or its licensors or joint venture partners, unless otherwise noted. All content of the MyBreastCancerTreatment.org Web site, including any images or text, is protected by U.S. and foreign copyright laws and may not be distributed, downloaded, modified, reused, reposted, or otherwise used except that you may view, use, and download a single copy of this Web site for your informational, non-commercial use. Except as provided herein, no part of any content or software on this Web site may be copied, downloaded or stored in a retrieval system for any other purpose, nor may it be redistributed for any purpose, without the express written permission of Genomic Health. The use or misuse of Genomic Health's trademarks, service marks, copyrights, or other materials, except as permitted herein, is expressly prohibited and may be a violation of copyright law, trademark law, communications regulations and statutes, and other laws, statutes and/or regulations.

Genomic Health reserves the right to seek all remedies available at law and in equity for violations of these terms and conditions for using the MyBreastCancerTreatment.org Web site, including the right to block access from a particular Internet address to the Web site.

Genomic Health's Privacy Policy ("Privacy Policy"), as it may change from time to time, is a part of these terms and conditions for using the MyBreastCancerTreatment.org Web site and is incorporated herein by this reference. Genomic Health reserves the right, and you authorize Genomic Health, to the use and assignment of all information regarding your use of this Web site and all information provided by you in any manner consistent with Genomic Health's Privacy Policy.

If you have any questions about these terms and conditions, please let us know through our Contact Us page